Clinical Research Directory
Browse clinical research sites, groups, and studies.
Fructose Intestinal Gluconeogenesis
Sponsor: Touro University, California
Summary
This study will test the hypothesis that within a defined range of fructose intake, the ability to convert fructose to glucose (via gluconeogenesis) in the small intestine plays a protective role for the liver, shielding it from the deleterious effects of fructose. We will investigate whether this protective effect of the intestine is impaired in individuals with obesity.
Official title: Fructose Metabolism Effects on the Liver: Unraveling the Role of Defective Intestinal GNG in Individuals With Obesity
Key Details
Gender
All
Age Range
20 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-03-02
Completion Date
2030-06
Last Updated
2026-03-06
Healthy Volunteers
Yes
Interventions
High fructose meal
Liquid meals containing 55% total carbohydrate (16% fructose), 30% fat, 15% protein.
Low fructose meal
55% total carbohydrate (6% fructose), 30% fat, 15% protein.
13C labeled fructose, oral
Tracer amount of 13C labeled fructose administered orally in the meals.
13C labeled fructose, intravenous
Tracer amount of 13C fructose administered intravenously
Locations (1)
Touro University California
Vallejo, California, United States